P23 Assessing the Long-term Outcomes of Ocrelizumab Treatment in Germany – CONFIDENCE Baseline Characteristics. Issue 4 (April 2020) - van Hall, V.; Hartung, H.P.; Dirks, P.; Eggebrecht, J.; Hieke-Schulz, S.; Leemhuis, J.; Wormser, D.; Ziemssen, T.